JP2004215669A5 - - Google Patents

Download PDF

Info

Publication number
JP2004215669A5
JP2004215669A5 JP2004064978A JP2004064978A JP2004215669A5 JP 2004215669 A5 JP2004215669 A5 JP 2004215669A5 JP 2004064978 A JP2004064978 A JP 2004064978A JP 2004064978 A JP2004064978 A JP 2004064978A JP 2004215669 A5 JP2004215669 A5 JP 2004215669A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004064978A
Other languages
Japanese (ja)
Other versions
JP2004215669A (ja
JP3811745B2 (ja
Filing date
Publication date
Priority claimed from DE19944412177 external-priority patent/DE4412177C1/de
Application filed filed Critical
Publication of JP2004215669A publication Critical patent/JP2004215669A/ja
Publication of JP2004215669A5 publication Critical patent/JP2004215669A5/ja
Application granted granted Critical
Publication of JP3811745B2 publication Critical patent/JP3811745B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004064978A 1994-04-08 2004-03-09 アポトーシス阻害剤 Expired - Lifetime JP3811745B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19944412177 DE4412177C1 (de) 1994-04-08 1994-04-08 Hemmer von Apoptose

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP52603195A Division JP3778453B2 (ja) 1994-04-08 1995-02-16 アポプトシス阻害剤

Publications (3)

Publication Number Publication Date
JP2004215669A JP2004215669A (ja) 2004-08-05
JP2004215669A5 true JP2004215669A5 (cg-RX-API-DMAC7.html) 2005-06-09
JP3811745B2 JP3811745B2 (ja) 2006-08-23

Family

ID=6514949

Family Applications (2)

Application Number Title Priority Date Filing Date
JP52603195A Expired - Lifetime JP3778453B2 (ja) 1994-04-08 1995-02-16 アポプトシス阻害剤
JP2004064978A Expired - Lifetime JP3811745B2 (ja) 1994-04-08 2004-03-09 アポトーシス阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP52603195A Expired - Lifetime JP3778453B2 (ja) 1994-04-08 1995-02-16 アポプトシス阻害剤

Country Status (8)

Country Link
US (1) US20070207160A1 (cg-RX-API-DMAC7.html)
EP (1) EP0705278B1 (cg-RX-API-DMAC7.html)
JP (2) JP3778453B2 (cg-RX-API-DMAC7.html)
AT (1) ATE255129T1 (cg-RX-API-DMAC7.html)
DE (1) DE4447484C2 (cg-RX-API-DMAC7.html)
DK (1) DK0705278T3 (cg-RX-API-DMAC7.html)
ES (1) ES2211899T3 (cg-RX-API-DMAC7.html)
WO (1) WO1995027735A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2215905A1 (en) 1995-03-20 1996-09-26 Sumitomo Electric Industries, Ltd. Monoclonal antibody reacting specifically with fas ligand and process for producing the same
AU6091496A (en) * 1995-06-07 1996-12-30 Chiron Corporation Antibodies to fas antigen capable of inhibiting apoptosis
US6096312A (en) * 1995-06-30 2000-08-01 Mochida Pharmaceutical Co., Ltd. Agent for suppressing a reduction of CD4+ lymphocytes
JPH09124509A (ja) * 1995-10-27 1997-05-13 Sumitomo Electric Ind Ltd 肝炎治療剤
DE19544333C2 (de) * 1995-11-28 1998-12-10 Deutsches Krebsforsch Verfahren zur Beurteilung der Aktivität von Arzneistoffen
WO1997039722A2 (en) * 1996-04-25 1997-10-30 T Cell Sciences, Inc. Method of isolating regulators of t cell activation
GB9703276D0 (en) * 1997-02-17 1997-04-09 Screaton Gavin R Materials and methods relating to the protection of useful immune cells
EP1025242A1 (en) * 1997-10-30 2000-08-09 Cornell Research Foundation, Inc. A method of inhibiting an immune response to a recombinant vector
EP1447093A1 (en) 2003-02-14 2004-08-18 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries
WO2004085479A2 (en) 2003-03-26 2004-10-07 Apogenix Gmbh Treatment of viral infections
US9309320B2 (en) 2006-12-28 2016-04-12 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
EP2310409A2 (en) 2008-06-17 2011-04-20 Apogenix GmbH Multimeric tnf receptors
CN102497886B (zh) * 2009-07-21 2016-01-20 玛丽皇后与斯特菲尔德学院 用于细胞内药物递送的Fas(Apo-1,CD95)靶向平台
JP6297552B2 (ja) 2012-07-18 2018-03-20 アポジェニックス アーゲー Mdsの治療のための、cd95シグナル伝達経路阻害剤
EP3076179A1 (en) 2015-03-30 2016-10-05 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Diagnosis and treatment of low grade gliomas
TWI788307B (zh) 2016-10-31 2023-01-01 美商艾歐凡斯生物治療公司 用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
AU2018205234B2 (en) 2017-01-06 2024-09-19 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes (TILs) with tumor necrosis factor receptor superfamily (TNFRSF) agonists and therapeutic combinations of TILs and TNFRSF agonists
ES3055314T3 (en) 2017-01-06 2026-02-11 Iovance Biotherapeutics Inc Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof
WO2018209115A1 (en) 2017-05-10 2018-11-15 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
JP2021503885A (ja) 2017-11-22 2021-02-15 アイオバンス バイオセラピューティクス,インコーポレイテッド 末梢血からの末梢血リンパ球(pbl)の拡大培養
EP3724885A2 (en) 2017-12-15 2020-10-21 Iovance Biotherapeutics, Inc. Systems and methods for determining the beneficial administration of tumor infiltrating lymphocytes, and methods of use thereof and beneficial administration of tumor infiltrating lymphocytes, and methods of use thereof
CA3090795A1 (en) 2018-02-13 2019-08-22 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes (tils) with adenosine a2a receptor antagonists and therapeutic combinations of tils and adenosine a2a receptor antagonists
SG11202109331QA (en) 2019-03-01 2021-09-29 Iovance Biotherapeutics Inc Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
CN114269370A (zh) 2019-03-29 2022-04-01 迈斯特治疗公司 离体产生t细胞治疗剂的方法以及相关的组合物和方法
IL293350A (en) 2019-11-27 2022-07-01 Myst Therapeutics Llc Method of producing tumor-reactive t cell composition using modulatory agents
EP4110799B1 (en) 2020-02-27 2024-11-06 Turnstone Biologics Corp. Methods for ex vivo enrichment and expansion of tumor reactive t cells and related compositions thereof
US20260124242A1 (en) 2022-11-04 2026-05-07 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
WO2026044087A1 (en) 2024-08-21 2026-02-26 Shape Therapeutics Inc. Increased cellular stability for aav production
WO2026073032A1 (en) 2024-09-27 2026-04-02 Shape Therapeutics Inc. Constructs for improved aav production

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486344A (en) * 1983-03-28 1984-12-04 Miles Laboratories, Inc. Urea-linked immunogens, antibodies, and preparative method
DK354487A (da) * 1986-07-11 1988-01-12 Noboru Yanaihara Oncogen-relaterede peptider
PT90657B (pt) * 1988-05-27 1995-03-01 Ortho Pharma Corp Processo para a preparacao de peptidos que bloqueiam a ligacao de hiv-1 a proteina cd4 receptora
EP0522081A4 (en) * 1990-03-30 1993-06-16 Smithkline Beecham Corporation Inhibition of disease associated with immunodeficiency virus infection
CA2067031C (en) * 1991-04-26 2003-02-18 Shigekazu Nagata Dna coding for human cell surface antigen
US5830469A (en) * 1993-10-14 1998-11-03 Immunex Corporation Fas antagonists and uses thereof
NZ275711A (en) * 1993-10-14 1998-03-25 Immunex Corp Monoclonal antibodies and binding proteins which bind to human fas antigen (nerve growth factor/tumour necrosis factor receptor type)

Similar Documents

Publication Publication Date Title
JP2004288168A5 (cg-RX-API-DMAC7.html)
JP2004332738A5 (cg-RX-API-DMAC7.html)
JP2004297999A5 (cg-RX-API-DMAC7.html)
BRPI0515516B8 (cg-RX-API-DMAC7.html)
IN2007CH02034A (cg-RX-API-DMAC7.html)
ECSDI055830S (cg-RX-API-DMAC7.html)
JP2005039214A5 (cg-RX-API-DMAC7.html)
IN2006DE03675A (cg-RX-API-DMAC7.html)
JP2005212877A5 (cg-RX-API-DMAC7.html)
ECSDI045281S (cg-RX-API-DMAC7.html)
JP2005232645A5 (cg-RX-API-DMAC7.html)
JP2005193443A5 (cg-RX-API-DMAC7.html)
JP2004298622A5 (cg-RX-API-DMAC7.html)
JP2005273162A5 (cg-RX-API-DMAC7.html)
DE502005004757D1 (cg-RX-API-DMAC7.html)
JP2005225494A5 (cg-RX-API-DMAC7.html)
DE602005017471D1 (cg-RX-API-DMAC7.html)
JP2005223840A5 (cg-RX-API-DMAC7.html)
IN2004DE00514A (cg-RX-API-DMAC7.html)
JP2004237739A5 (cg-RX-API-DMAC7.html)
JP2004355029A5 (cg-RX-API-DMAC7.html)
JP2005235012A5 (cg-RX-API-DMAC7.html)
CN300883204S (zh) 数据处理设备及相关仪器装置的罩壳
CN300732651S (zh) 起动器的主体
CH698605C1 (cg-RX-API-DMAC7.html)